Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fonatsch

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Leukemia|January 19, 2000
Drug resistance factors in acute myeloid leukemia: a comparative analysisM Filipits, T Stranzl, G Pohl, et al.
Annals of Hematology|August 31, 1999
Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemiaH Agis, A Weltermann, G Mitterbauer, et al.
Leukemia|October 12, 1999
Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCRG Mitterbauer, C Zimmer, C Fonatsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID miceU Kapp, A Düx, E Schell-Frederick, et al.
British Journal of Haematology|May 1, 2001
Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi-solid colony growthL Ohler, A Berer, D Aletaha, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Evidence for the identity of human scatter factor and human hepatocyte growth factorK M Weidner, N Arakaki, G Hartmann, et al.
Blood|August 15, 1993
Hodgkin's lymphoma-derived tissue serially transplanted into severe combined immunodeficient miceU Kapp, J Wolf, M Hummel, et al.
Leukemia|August 1, 1994
Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)C Fonatsch, H Gudat, E Lengfelder, et al.
Leukemia & Lymphoma|June 1, 1999
Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significanceS Schwartz, A Heinecke, M Zimmermann, et al.
Lancet (London, England)|May 4, 1991
Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reactionJ Maurer, J W Janssen, E Thiel, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Leukemia|January 19, 2000
Drug resistance factors in acute myeloid leukemia: a comparative analysisM Filipits, T Stranzl, G Pohl, et al.
Annals of Hematology|August 31, 1999
Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemiaH Agis, A Weltermann, G Mitterbauer, et al.
Leukemia|October 12, 1999
Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCRG Mitterbauer, C Zimmer, C Fonatsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID miceU Kapp, A Düx, E Schell-Frederick, et al.
British Journal of Haematology|May 1, 2001
Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi-solid colony growthL Ohler, A Berer, D Aletaha, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Evidence for the identity of human scatter factor and human hepatocyte growth factorK M Weidner, N Arakaki, G Hartmann, et al.
Blood|August 15, 1993
Hodgkin's lymphoma-derived tissue serially transplanted into severe combined immunodeficient miceU Kapp, J Wolf, M Hummel, et al.
Leukemia|August 1, 1994
Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)C Fonatsch, H Gudat, E Lengfelder, et al.
Leukemia & Lymphoma|June 1, 1999
Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significanceS Schwartz, A Heinecke, M Zimmermann, et al.
Lancet (London, England)|May 4, 1991
Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reactionJ Maurer, J W Janssen, E Thiel, et al.
Pageof 16